About InnoCure Therapeutics
InnoCure Therapeutics is a Healthcare company based in Seongnam-si (South Korea) founded in 2018 by Hye Dong Yoo. Provider of small molecules based drug for altering the cellular function and pathogenic proteins. Its chief executive, as recorded, is Hye Dong Yoo. InnoCure Therapeutics offers products and services including Resume Writing Service, Cover Letter Service, and Sample Documents. Its focus areas include Life Sciences, Infectious Diseases, Drugs and Diversified. Its legal entity in India is κΈκ³Ό μ¬λλ€ (U99999MH1977PLC010754).
Company details
InnoCure Therapeutics was founded in 2018 and is based in Seongnam-si, South Korea. Operations focus on the biotechnology sector, where small molecule-based drugs are developed to modify cellular functions and address pathogenic proteins. The flagship TDbUM platform targets the ubiquitin-proteasome system and autophagy pathways, enabling the degradation of undruggable proteins to support cellular homeostasis. Services emphasize therapeutic solutions for protein-related disorders.
- Headquarters Seongnam-si, South Korea
- Founders Hye Dong Yoo
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website innocurethera.com
- Legal Name 글과 사람들
- Date of Incorporation 10 Aug, 1977
- Jurisdiction Maharashtra, India
Associated legal entities of InnoCure Therapeutics
InnoCure Therapeutics operates through , (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| , CIN U99999MH1977PLC010754 | Active | 10 Aug 1977 | Nanded, Maharashtra | View details |
Products & Services of InnoCure Therapeutics
InnoCure Therapeutics offers a comprehensive portfolio of products and services, including Resume Writing Service, Cover Letter Service, and Sample Documents.
Provides professional resume creation for job applications
Assists in drafting effective cover letters for employment
Offers templates for resumes and letters to aid self-preparation
People of InnoCure Therapeutics
1 people are tracked at InnoCure Therapeutics (1 in leadership).
| Name | Role | Group |
|---|---|---|
Hye Dong Yoo | Founder & CEO | Leadership |
Complete people profiles for InnoCure Therapeutics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Web traffic of InnoCure Therapeutics
The website of InnoCure Therapeutics (innocurethera.com) receives about 2.2K visits a month.
- Monthly visits2.2K
▼ 24.6% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Innocure Therapeutics
Complete news archive for InnoCure Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about InnoCure Therapeutics
InnoCure Therapeutics was founded in 2018.
InnoCure Therapeutics is headquartered in Seongnam-si, South Korea. It is registered at Seongnam-si, Gyeonggi-do, South Korea.
Hye Dong Yoo is the CEO of InnoCure Therapeutics, as recorded in our data. They have also founded this company.
InnoCure Therapeutics was founded in 2018 and is based in Seongnam-si, South Korea. Operations focus on the biotechnology sector, where small molecule-based drugs are developed to modify cellular functions and address pathogenic proteins. The flagship TDbUM platform targets the ubiquitin-proteasome system and autophagy pathways, enabling the degradation of undruggable proteins to support cellular homeostasis. Services emphasize therapeutic solutions for protein-related disorders.
InnoCure Therapeutics offers Resume Writing Service, Cover Letter Service, and Sample Documents.
InnoCure Therapeutics operates through ,.